Optimizing urate-lowering therapy to achieve target serum urate levels may not harm, and may benefit, patients with gout and CKD. Despite clinician concerns, treating patients with gout and stage 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback